{
  "docId": "019de517-75a1-7387-968b-d0dc513bf421",
  "docSlug": "e930bfcc8684afb6f5a4dd5442b5166d",
  "documentTitle": "Ocuphire Pharma | Investor Presentation Deck | 42 slides",
  "authorId": "ocuphire-pharma",
  "authorName": "Ocuphire Pharma",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 17,
  "pageCount": 42,
  "prevPage": 16,
  "nextPage": 18,
  "slideType": "timeline",
  "function": "establish_context",
  "density": "overcrowded",
  "nDataPoints": 4,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019de517-75a1-7387-968b-d0dc513bf421/17",
  "deckHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421",
  "deckJsonHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421.json",
  "deckAnchorHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421#slide-17",
  "components": [
    {
      "bbox": {
        "h": 0.1,
        "w": 0.8,
        "x": 0.11,
        "y": 0.49
      },
      "kind": "diagram",
      "text": "Preclinical Efficacy & Toxicology Package -> APX3330 IND -> 6 Phase 1 Trials -> 5 Phase 2 Trials -> Phase 2 Trials -> Phase 3 Registration -> NDA Filing",
      "attrs": {},
      "subkind": "timeline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a2bb527b-bbc2-4ad6-8cff-3f9d1c2c1ea8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.23,
        "w": 0.12,
        "x": 0.17,
        "y": 0.18
      },
      "kind": "image",
      "text": "APX3330 New Chemical Entity",
      "attrs": {},
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f33bf968-0ec2-4db4-98ea-f74f09fa539b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.85,
        "x": 0.08,
        "y": 0.76
      },
      "kind": "list",
      "text": "Previously developed by Eisai for hepatic inflammatory indications and by Apexian for solid tumors in 11 Phase 1 and 2 trials",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a76e54c8-d2f4-4a12-afc8-55634dfb55d6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.84,
        "x": 0.08,
        "y": 0.87
      },
      "kind": "list",
      "text": "Extensively studied in over 20 in-vitro and animal studies with favorable efficacy and safety results",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c9d20d1f-377c-4b1f-b53c-c3c70ca66291",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.09,
        "x": 0.7,
        "y": 0.26
      },
      "kind": "metric",
      "text": "2035+",
      "attrs": {},
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3ab99e29-cf33-4a7d-af7a-51f59e36cdee",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.11,
        "x": 0.52,
        "y": 0.26
      },
      "kind": "metric",
      "text": ">10,000",
      "attrs": {},
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a081b439-583f-4094-a1f2-7e2b73cf73c4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.07,
        "x": 0.34,
        "y": 0.23
      },
      "kind": "metric",
      "text": "12*",
      "attrs": {},
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b34ada3d-57ef-4890-b1c6-5b8d140bcf3e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.11,
        "w": 0.13,
        "x": 0.51,
        "y": 0.21
      },
      "kind": "paragraph",
      "text": "Exposure in Humans\nSubject Days at 600mg/day",
      "attrs": {},
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "27d74544-22e8-4f02-a004-5a3500890c66",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.08,
        "x": 0.7,
        "y": 0.21
      },
      "kind": "paragraph",
      "text": "Patents to",
      "attrs": {},
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "863f86a0-4bd5-4e13-8c91-5752a28a07c3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.11,
        "x": 0.32,
        "y": 0.28
      },
      "kind": "paragraph",
      "text": "Phase 1 & Phase 2 Trials",
      "attrs": {},
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8ab6c5a7-e724-45f5-ab7a-efe830e75960",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.01,
        "w": 0.1,
        "x": 0.11,
        "y": 0.97
      },
      "kind": "source-note",
      "text": "Includes ZETA-1 trial",
      "attrs": {},
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4db945ab-1752-43b5-943f-d19526ffddd9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.69,
        "x": 0.05,
        "y": 0.06
      },
      "kind": "title",
      "text": "APX3330: Drug Development History and Patents",
      "attrs": {},
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "09aa7de2-a8d0-40a7-9d5d-2c6056522809",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.67,
        "x": 0.05,
        "y": 0.09
      },
      "kind": "title",
      "text": "Significant Preclinical & Clinical Data Supporting Human Safety, MOA, and PK",
      "attrs": {},
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "555478ef-d108-4f94-ba01-d296ac156fee",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 28,
      "from": 17,
      "beatId": "65814d93-901f-41c1-8ee8-b0d5c8ea9369",
      "arcName": "The Consultant's Gambit",
      "arcSlug": "consultants-gambit",
      "beatName": "Evidence & Proof",
      "beatSlug": "consultants-gambit-evidence-proof",
      "evidence": "Slides 17-28 provide clinical trial results and data for APX3330",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [
    {
      "to": 18,
      "from": 16,
      "name": "Aha Moment",
      "slug": "03-aha-moment",
      "bestFor": "Data-heavy sections, research findings, analytical arguments",
      "matchId": "06b3bd6b-dd7a-4246-9ad5-76e883655757",
      "evidence": "Slides 16-18 highlight APX3330's mechanism of action and in-vitro validation",
      "position": 0,
      "objective": "What makes APX3330 unique?",
      "structure": "The Problem/Question -> What the Data Shows -> The Insight",
      "confidence": 0.7,
      "description": "Establish a tension, present data, then deliver the insight that changes everything"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}